Shanghai INT Medical Instruments Co., Ltd.

SEHK:1501 Stock Report

Market Cap: HK$4.8b

Shanghai INT Medical Instruments Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

SEHK:1501 Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
12 Dec 24BuyHK$1,158,000China Orient Asset Management (International) Holding LimitedCompany40,000HK$28.95
05 Dec 24SellHK$29,533,098Huaige CapitalCompany1,051,000HK$28.10
19 Nov 24SellHK$147,398,504JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany5,254,848HK$28.05
18 Nov 24BuyHK$149,715,522JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany5,245,648HK$28.54
08 Nov 24SellHK$76,093,612JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany2,725,416HK$27.92
07 Nov 24BuyHK$170,731,320JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany6,097,547HK$28.00
18 Oct 24BuyHK$701,840China Orient Asset Management (International) Holding LimitedCompany24,800HK$28.30
04 Oct 24BuyHK$345,059JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany12,180HK$28.33
04 Oct 24SellHK$136,499,360JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany4,818,191HK$28.33
30 Sep 24SellHK$121,802,226JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany4,268,775HK$28.53
15 Jul 24BuyHK$160,791,598JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany6,102,147HK$26.35
30 May 24SellHK$955,850Huaige CapitalCompany35,000HK$27.31
21 May 24BuyHK$443,200China Orient Asset Management (International) Holding LimitedCompany16,000HK$27.70
08 May 24BuyHK$72,804,798JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany2,609,491HK$27.90
02 Apr 24SellHK$144,229,364JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany5,287,970HK$27.27

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 1501?
Owner TypeNumber of SharesOwnership Percentage
Employee Share Scheme2,400,0001.36%
Private Companies6,000,0003.41%
General Public15,311,7478.7%
Institutions22,829,05313%
VC/PE Firms34,489,20019.6%
Public Companies42,857,14224.4%
Individual Insiders52,112,85829.6%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 2.9%.

Top Shareholders

Top 21 shareholders own 91.3% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
24.4%
Shanghai Kindly Enterprise Development Group Co.,LTD.
42,857,142HK$1.2b0%no data
13.3%
Huaige Capital
23,377,000HK$638.2m-4.3%no data
6.92%
China Orient Asset Management (International) Holding Limited
12,175,800HK$332.4m7.82%18.27%
6.84%
Dongke Liang
12,042,854HK$328.8m0%no data
6.31%
OrbiMed Advisors LLC
11,112,200HK$303.4m0%0.53%
4.06%
Sen Lin
7,142,858HK$195.0m0%no data
4.06%
Ruiqin Wang
7,142,858HK$195.0m0%no data
4.02%
Xing Chen
7,071,430HK$193.1m0%no data
4.02%
Chubin Huang
7,071,430HK$193.1m0%no data
3.45%
Wei Ke
6,070,000HK$165.7m0%no data
3.41%
Ningbo Tongchuang Suwei Investment Partnership Enterprise (Limited Partnership)
6,000,000HK$163.8m0%no data
3.17%
Kai Wang
5,571,428HK$152.1m0%no data
1.97%
China Orient Asset Management Corporation, Asset Management Arm
3,473,600HK$94.8m53.4%2.97%
1.76%
UBS Asset Management AG
3,097,000HK$84.5m0%no data
1.36%
Ningbo Int Investment Partnership (Limited Partnership)
2,400,000HK$65.5m0%no data
0.75%
JPMorgan Chase & Co, Brokerage and Securities Investments
1,316,453HK$35.9m-0.15%no data
0.72%
Jingning Int Chuangqi Enterprise Management Partnership
1,261,400HK$34.4m0%no data
0.7%
Jingning Int Chuangyuan Enterprise Management Partnership (Limited Partnership)
1,238,600HK$33.8m0%no data
0.11%
Dimensional Fund Advisors LP
196,400HK$5.4m1.55%no data
0.025%
Fullgoal Fund Management Co. Ltd.
43,200HK$1.2m0%no data
0.015%
Allianz Asset Management GmbH
26,600HK$726.0k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/19 12:10
End of Day Share Price 2024/12/19 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Shanghai INT Medical Instruments Co., Ltd. is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullCMB International Securities Limited
Yu WuCMB International Securities Limited
Xin Qiu LinGuoyuan Securities (HK) Ltd